Erratum to: Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD)

被引：0
|
作者：
Katelyn R. Keyloun
Ryan N. Hansen
Zsolt Hepp
Patrick Gillard
Michael E. Thase
Emily Beth Devine
机构：
[1] Global Health Outcomes Strategy and Research,Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy
[2] Allergan,undefined
[3] University of Washington,undefined
[4] Perelman School of Medicine at the University of Pennsylvania,undefined
来源：
CNS Drugs | 2017年 / 31卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：511 / 511
相关论文
共 32 条
  • [1] Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD)
    Katelyn R. Keyloun
    Ryan N. Hansen
    Zsolt Hepp
    Patrick Gillard
    Michael E. Thase
    Emily Beth Devine
    [J]. CNS Drugs, 2017, 31 : 421 - 432
  • [2] Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD)
    Keyloun, Katelyn R.
    Hansen, Ryan N.
    Hepp, Zsolt
    Gillard, Patrick
    Thase, Michael E.
    Devine, Emily Beth
    [J]. CNS DRUGS, 2017, 31 (05) : 421 - 432
  • [3] Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD) (vol 31, pg 421, 2017)
    Keyloun, Katelyn R.
    Hansen, Ryan N.
    Hepp, Zsolt
    Gillard, Patrick
    Thase, Michael E.
    Devine, Emily Beth
    [J]. CNS DRUGS, 2017, 31 (06) : 511 - 511
  • [4] A RETROSPECTIVE STUDY OF TREATMENT DISPARITIES IN DEMOGRAPHICS FOR MAJOR DEPRESSIVE DISORDER (MDD) USING CLAIMS DATA IN THE US
    Chopra, A.
    Gaur, A.
    Kukreja, I
    Daral, S.
    Nayyar, A.
    Verma, V.
    Pandey, S.
    Roy, A.
    Bhalani, S.
    Rawat, M.
    Sharma, S.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S467 - S467
  • [5] ANTIDEPRESSANT TREATMENT PATTERNS, HEALTH CARE UTILIZATION AND COST AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD)
    Isenberg, K.
    Eisenberg, D.
    Sanchez, R.
    Alvir, J.
    Wang, J.
    Gu, T.
    White, J.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A89 - A89
  • [6] Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data
    Solem, Caitlyn T.
    Shelbaya, Ahmed
    Wan, Yin
    Deshpande, Chinmay G.
    Alvir, Jose
    Pappadopulos, Elizabeth
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2016, 12 : 2755 - 2764
  • [7] Adherence to, and Persistence of, Antidepressant Therapy in Patients with Major Depressive Disorder: Results from a Population-based Study in Italy
    Di Nicola, Marco
    Dell'Osso, Bernardo
    Peduto, Ilaria
    Cipelli, Riccardo
    Pugliese, Anna Cristina
    Signorelli, Maria Salvina
    Ventriglio, Antonio
    Martinotti, Giovanni
    [J]. CURRENT NEUROPHARMACOLOGY, 2023, 21 (03) : 727 - 739
  • [8] Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder
    Liu, Xianchen
    Chen, Yi
    Faries, Douglas E.
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2011, 3 : 63 - 72
  • [9] Adherence and persistence among patients with major depressive disorder enrolled in the vortioxetine tAccess Patient Support Program
    Lawrence, Debra F.
    Manjelievskaia, Janna
    Chrones, Lambros
    McCue, Maggie
    Touya, Maelys
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (08) : 1385 - 1392
  • [10] Treatment Patterns During Major Depressive Episodes Among Patients with Major Depressive Disorder: A Retrospective Database Analysis
    Rakesh Jain
    Sara Higa
    Katelyn Keyloun
    Julie Park
    Machaon Bonafede
    Amy Tung
    Patrick Gillard
    Andrew J. Cutler
    [J]. Drugs - Real World Outcomes, 2022, 9 : 477 - 486
1234